论文信息 - Efficacy and safety of crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC). - 字舞流文

Efficacy and safety of crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC).

Jeffrey W. Clark | A. Iafrate | J. Engelman | K. Bergethon | A. Shaw | S. Ou | Gregory Riely | Y. Bang | R. Salgia | M. Varella‐Garcia | G. Shapiro | P. Stephenson | L. Tye | K. Wilner | B. Solomon | D. Camidge | E. Kwak | M. Varella-Garcia